Jenkoo (@Jenkoool) profile picture

AIM Investor

Joined February 2022
Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)Photo by Jenkoo (@Jenkoool)
HUGE announcement from $LLY CEO Dave Ricks We are so back 🇺🇸
$NVO having a difficult time stocking Semaglutide... Meanwhile $LLY built up $550MM stockpile of orforglipron and it's not even approved 🤣
3
6
1
29
10,498
BREAKING NEWS; The Petition calling for Another GENERAL ELECTION due to the Mistruths ok Lies told by ⁦@Keir_Starmer⁩ & @RachelReevesMP⁩ who have BREACHED their promises has surpassed>10,000 mark NOW? 100,000👇 Call a General Election - Petitions petition.parliament.uk/petit…
1,172
3,893
373
9,291
873,912
Jenkoo retweeted
Great to see so much interest in the poster presentations of our two novel preCISION programs at #ENASymp24! #AVCT
5
25
1
232
10,311
Good chance #AVCT ‘s CC & NED DD-H have been sounding out US investors for a NASDAQ list raise. CC’s ‘I know them’ comment wrt US II’s, DD-H’s deep capital markets experience & the company openly discussing the goal of listing, clearly makes this a plausible scenario.
1
1
27
3,292
#AVCT Enhertu barely scratching the surface, in solid tumour treatment at least. With 2023 revs of $2.556 Bn, x by 6 for a FAP targeted approach = $15.336bn + conservative pharma multiple (6.2) = $95.0832 bn (Less a tonne of undesirable SE’s) The opportunity is monstrous!
3
4
35
3,419
#AIM would certainly put cat amongst the pigeons!! Perhaps a wake up call to the huge lag in values here…
6
13
1
50
9,251
The Times 'Exodus from AIM leaves chorus of questions in its wake'
9
13
3
44
17,497
NEW TYPE OF WEAPON TO DELIVER CHEMO PRECISELY ON TARGET: @AACR @avacta revealed the very first results from a new way to attack cancer. Imagine chemo only hitting tumors+not ALL your cells,that's the idea here.Definitely one to watch! avacta.com/avacta-therapeuti…
4
13
2
66
5,130
A reminder that in 2015 Ketruda posted a 75% disease control rate on 1 specially selected indication in order to increase chances of positive results. #AVCT just posted 67% which included numerous tumours known to not be responsive to dox.
3
8
57
4,216
The ones who understand the tech would be devastated if an offer of say £6 was offered to the market and accepted due to lack of funds who do understand to be able to block it. #AVCT 2/2
3
4
30
2,373
My thoughts following the #GBP interview.. unicorn.
Very good interview by new bod member Daniel. Touched on the recent joint venture... Opportunities of a Producing asset is very significant and excited to pursue that...! Hopefully we get some big new soon of a producing asset funded via the JV 🤑 it will multibag off that #GBP
5
3
1
10
2,058
#gbp Now for those who are wondering how strong this partnership with cynergy are then look at the key members are of each board and you’ll realise the scale level #gbp is working with Cynergy 💥Mike germanos - founder and highly connected in the $oil space including gulf sovereign wealth funds aka royal families 💥Richard Luddington - senior advisor to Rothschild, clients are governments and institutions 💥Nick Cochrane-Dyet - senior advisor to BP Chief Representative in Abu Dhabi and chairs the Middle East Advisory Board of the Energy Industry Council 💥Sir Graham Hugh Boyce - former advisor to Lehman brothers in Middle East, now current advisor to Namora. Former diplomat 💥Yaacov Amidror - former security adviser to government #gbp 💥Daniel page - former head of asset management kpmg 💥Cecilia Yu - credit trader and founder of billion dollar hedge fund 💥Azib khan - actuary and equities research This is a mega team forming here ✅ political connections ✅sovereign wealth fund connections, ✅senior advisors to TIER 1 $oil and gas companies ✅connections to Middle East $oil and gas ✅News Articles showing cynergy looking at multi billion dollar projects ✅Daniel and Cecilia expertise and connections using #gbp imo to be part of this Something really incredible is being here and now I think Daniel page was being prudent when saying 250m market cap
1
2
2
4
2,433
Jenkoo retweeted
BBIO, $7Bn, Rev? $9.4m RETA, $7.3Bn, Rev? $22m GRCL, $1.2Bn, Rev? Nil CBAY, $2.7Bn, Rev? $30m AUTL, $1.12Bn, Rev? $406k NUVL, $4.61Bn, Rev? Nil #AVCT, £330m, Rev? £20m+
If #AVCT is on your watchlist for 2024, check the US biotech darlings of 2023, then check their rev. GRCL really stands out for me. A basket of INDs for £950m. AVCT could put itself up for sale and sell for more, if it downed every tool tomorrow. All the best for 24.
3
3
38
8,696
#AVCT AVA6000 (up to 385 mg/m2) vs Enhertu (% of grade 3-4 SAE’s) Neutropenia 7.5/28.7 Anemia 5/22.6 Febrile neutropenia 0/1.2 leukopenia 0/13.3 Thrombocytopenia 5/9.1 Decreased wbc count 5/71 Mucositis/stomatitis 2.5/20 Fatigue 2.5/7.1
7
9
1
52
14,830
Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell. [📹 Alex Ritter] xitter.gq/RKian_Service/status/1…
264
2,904
268
27,551
6,409,918
#PREM #Lithium #Tesla #STARK #Mining #EVs #GreenEnergy #Spodumene #SC6 #Zimbabwe #Canmax #Li3 #AIM #FTSE #CATL Further excellent detective work from our Pat. 👇🏻
2
10
26
2,207
Head of program innovation, Global Drug Development at Novartis also believes #AVCT could be realising a paradigm shift in cancer treatment with pre|CISION Things going to get real interesting real soon with this stock. This is the big one guys. This is it.
15
26
9
188
81,204
Last time I heard of paradigm change/shift in biotech, it was for MRNA technology... Whats that valued at?! Now you see the potential realising itself. Billions. #avct
1
4
66
25,317
Jenkoo retweeted
...almost 200 life science companies. We have access to a huge talent pool from Imperial College and several other London Universities, and have completed a recruitment round to ensure we have access to cutting edge drug discovery in our labs.”
2
1
26
3,599
Jenkoo retweeted
#AVCT has a leak. Look at the book. Zilch available.
1
8
1
45
6,175